Results 71 to 80 of about 126,577 (290)

BMP und SMAD Signale im kardiovaskulären System [PDF]

open access: yes, 2011
Der BMP/Smad-Signalweg ist an der Regulation vielfältiger Prozesse während derKardiogenese beteiligt. Aufgrund dieser Vielfalt ist der BMP-Signalweg ein mögliches Zieltherapeutischer Ansätze zur Behandlung kardiovaskulärer Erkrankungen. Bisher jedoch ist
Bücker, Sandra
core   +1 more source

Establishment of a Responsive Tooth‐on‐a‐Chip Platform for the Assessment of Regenerative Factors in Dental Tissue Regeneration

open access: yesAdvanced Healthcare Materials, EarlyView.
Using a tooth‐on‐a‐chip model that recreates interactions between dental epithelial and mesenchymal cells, the authors show that sequential FGF10+BMP4, BMP2, and Emdogain produce distinct, biologically consistent regenerative responses. The platform recapitulates known signal‐specific effects and, for the first time, reveals an influence of Emdogain on
Chong Huang   +3 more
wiley   +1 more source

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

open access: yesFrontiers in Pharmacology, 2022
Chronic kidney disease (CKD) was a major public health problem worldwide. Renal fibrosis, especially tubulointerstitial fibrosis, is final manifestation of CKD.
Xiao-Yong Yu   +4 more
doaj   +1 more source

Regulation of Smad Activity [PDF]

open access: yesCell, 2000
The Smads have emerged as a family of transcriptional comodulators that interact with a wide range of DNA-binding proteins to regulate their activity in response to TGFβ family signaling. Smad function in this regard is intimately linked to how much Smad is in the nucleus and this is subjected to extensive regulation both prior to and after activation ...
openaire   +2 more sources

Simulations and experiments for P-Smad Degradation.

open access: yes, 2014
(A) Model 6 with P-Smad Degradation and R-Smad Dephosphorylation (but no Receptor Degradation) was fitted to both the short-exposure (red) and long-exposure (blue) experimental data.
Hanry Yu (172694)   +6 more
core   +1 more source

A Coaxial Bioprinted Hydrogel With Semipermeable Sheath and Pro‐Chondrogenic Core for Articular Cartilage Repair

open access: yesAdvanced Materials, EarlyView.
A sheath‐core biomimetic hydrogel is engineered with a compartmentalized yet integrated architecture for synergistic multifunctionality. Its stiff, semipermeable sheath mimics the ECM's load‐bearing and protective roles, encapsulating a soft core that provides a pro‐chondrogenic microenvironment similar to the PCM.
Zheyuan Shi   +9 more
wiley   +1 more source

El factor de crecimiento transformante beta como blanco terapéutico Transforming growth factor-beta as a therapeutic target

open access: yesSalud Pública de México, 2004
El factor de crecimiento transformante beta (TGF-beta) es una familia de proteínas que incluye al TGF-beta, activinas y a la proteína morfogénica de hueso (BMP, por sus siglas en inglés), citocinas que son secretadas y se relacionan estructuralmente en ...
Francisco Javier Gálvez-Gastélum   +2 more
doaj  

Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. [PDF]

open access: yesPLoS ONE, 2010
We have recently described that in an experimental model of atherosclerosis and in vascular smooth muscle cells (VSMCs) statins increased the activation of the Smad pathway by transforming growth factor-β (TGF-β), leading to an increase in TGF-β ...
Raúl Rodrigues Díez   +10 more
doaj   +1 more source

Smad signalling network [PDF]

open access: yesJournal of Cell Science, 2002
Dimeric ligands of the transforming growth factor β (TGF-β) superfamily bind with high affinity to type II and type I receptor serine/threonine kinases on the cell surface and induce hetero-tetrameric receptor complexes. In such complexes, constitutively auto-phosphorylated type II receptors (
openaire   +2 more sources

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy